Modulation of tumor necrosis factor-alpha production with anti-hypertensive drugs. (Q54050714)

24 May 2018

title

Modulation of tumor necrosis factor-alpha production with anti-hypertensive drugs. (English)

1 reference

24 May 2018

author name string

Fukuzawa M

1

1 reference

24 May 2018

Satoh J

2

1 reference

24 May 2018

Ohta S

3

1 reference

24 May 2018

Takahashi K

4

1 reference

24 May 2018

Miyaguchi S

5

1 reference

24 May 2018

Qiang X

6

1 reference

24 May 2018

Sakata Y

7

1 reference

24 May 2018

Nakazawa T

8

1 reference

24 May 2018

Takizawa Y

9

1 reference

24 May 2018

Toyota T

10

1 reference

24 May 2018

publication date

1 June 2000

1 reference

24 May 2018

published in

Immunopharmacology

1 reference

24 May 2018

volume

48

1 reference

24 May 2018

issue

1

1 reference

24 May 2018

page(s)

65-74

1 reference

24 May 2018

The link between insulin resistance and hypertension. Effects of antihypertensive and antihyperlipidaemic drugs on insulin sensitivity

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2800%2900179-X

7 January 2021

Prostacyclin analogs suppress the synthesis of tumor necrosis factor-alpha in LPS-stimulated human peripheral blood mononuclear cells

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2800%2900179-X

7 January 2021

Modulation of lipopolysaccharide-induced tumor necrosis factor-alpha production by selective alpha- and beta-adrenergic drugs in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2800%2900179-X

7 January 2021

Angiotensin converting enzyme inhibitors suppress production of tumor necrosis factor-alpha in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2800%2900179-X

7 January 2021

Inhibitory effect of nicotinamide on in vitro and in vivo production of tumor necrosis factor-alpha

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2800%2900179-X

7 January 2021

Inhibition of tumor necrosis factor-alpha with anti-diabetic agents

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2800%2900179-X

7 January 2021

Improvement of insulin sensitivity for glucose metabolism with the long-acting Ca-channel blocker amlodipine in essential hypertensive subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2800%2900179-X

7 January 2021

Comparative pharmacokinetics of nicardipine hydrochloride, a new vasodilator, in various species

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2800%2900179-X

7 January 2021

Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2800%2900179-X

7 January 2021

Effect of doxazosin on insulin sensitivity in hypertensive non-insulin dependent diabetic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2800%2900179-X

7 January 2021

Effects of a calcium channel blocker, manidipine, on insulin sensitivity in essential hypertensives.

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2800%2900179-X

7 January 2021

The metabolism and kinetics of doxazosin in man, mouse, rat and dog.

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2800%2900179-X

7 January 2021

Effect of angiotensin-converting-enzyme (ACE) inhibitor trandolapril on human diabetic neuropathy: randomised double-blind controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2800%2900179-X

7 January 2021

Natriuretic action of manidipine hydrochloride, a new calcium channel blocker, in spontaneously hypertensive rats

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2800%2900179-X

7 January 2021

Free radical generation, lipid peroxidation and essential fatty acids in uncontrolled essential hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2800%2900179-X

7 January 2021

Gliclazide inhibits diabetic neuropathy irrespective of blood glucose levels in streptozotocin-induced diabetic rats

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2800%2900179-X

7 January 2021

Inhibitory effect of troglitazone on diabetic neuropathy in streptozotocin-induced diabetic rats

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2800%2900179-X

7 January 2021

Inhibition of cyclic amp phosphodiesterase by 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid 3-[2-(N-benzyl-N-methylamino)] ethyl ester 5-methyl ester hydrochloride (YC-93), a potent vasodilator

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2800%2900179-X

7 January 2021

Nicardipine may impair glucose metabolism in hypertensive diabetic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2800%2900179-X

7 January 2021

Recombinant human tumor necrosis factor alpha suppresses autoimmune diabetes in nonobese diabetic mice

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2800%2900179-X

7 January 2021

The metabolism and pharmacokinetics of amlodipine in humans and animals

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2800%2900179-X

7 January 2021

Increased in vivo production of tumor necrosis factor after development of diabetes in nontreated, long-term diabetic BB rats

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2800%2900179-X

7 January 2021

Cholesterol, calcium and atherosclerosis: is there a role for calcium channel blockers in atheroprotection?

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2800%2900179-X

7 January 2021

Noradrenaline inhibits lipopolysaccharide-induced tumor necrosis factor and interleukin 6 production in human whole blood.

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2800%2900179-X

7 January 2021

10.1016/S0162-3109(00)00179-X

Identifiers

DOI

1 reference

24 May 2018

PubMed ID

10822090

1 reference

24 May 2018